The Epidemiology, Etiology, Clinical Features, and Natural History of Emphysema

Thoracic Surgery Clinics

Volumn 19, Issue 2, 2009, Pages 149-158

  Kemp, Samuel V ^a   Polkey, Michael I ^a   Shah, Pallav L ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Etiology; Natural history; Smoking

Indexed keywords

FUEL;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ANAMNESIS; BIOMASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISABILITY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; EMPHYSEMA; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; GENE MUTATION; GENETIC ASSOCIATION; HEREDITY; HUMAN; HYPOTHESIS; INDUSTRY; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING; TOBACCO;

HUMANS; PULMONARY EMPHYSEMA; RISK FACTORS;

EID: 66249137812     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2009.03.003     Document Type: Review

References (63)

1. Ruysch F. Observationum anatomico-chirurgicarum centuria (1691), Boom, Amsterdam Obs XIX, XX
2. Baille M. The morbid anatomy of some of the most important parts of the human body (1793), Johnson and Nicol, London
3. Baille M. A series of engravings, accompanied with explanations which are intended to illustrate the morbid anatomy of the most important parts of the human body (1799), W. Bulmer, London
4. Laennec R.T.H. A treatise on the diseases of the chest and on mediate auscultation. Fourth London edition. Translated by J. Forbes (1835), Thomas and Co., Philadelphia
5. Orsos F. Au uber das elastische Gerauust der normalen und der emphysematosen Lunge. Pathol Anat 41 (1907) 95-121
6. Gough L. The pathological diagnosis of emphysema. Proc R Soc Med 45 9 (1952) 576-577
7. Leopold J.G., and Gough J. The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax 12 3 (1957) 219-235
8. Fishman A., Martinez F., Naunheim K., et al., National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003) 2059-2073
9. Strange C., Herth F.J., Kovitz K.L., et al., VENT Study Group. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med 7 (2007) 10
10. Wood D.E., McKenna Jr. R.J., Yusen R.D., et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 133 1 (2007) 65-73
11. Rabe K.F., Hurd S., Anzueto A., et al. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 6 (2007) 532-555
12. Pauwels R.A., Buist A.S., Calverly P.M., et al. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 5 (2001) 1256-1276
13. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59 Suppl I (2004)
14. World Health Organisation. Chronic obstructive pulmonary disease. Fact sheet No 315; May 2008. Available at:. http://www.who.int/mediacentre/factsheets/fs315/en/
15. Mannino D.M., Gagnon R.C., Petty T.L., et al. Obstructive lung disease and low lung function in adults in the United States: data from the Nation Health and Nutrition Examination Survey 1988-1994. Arch Intern Med 160 (2000) 1683-1689
16. Soriano J.B., Maier W.C., Egger P., et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 55 (2000) 789-794
17. Gupta P.P., and Agarwal D. A 24-year old man with persistent progressive breathlessness: early onset COPD. Prim Care Respir J 16 (2007) 387-390
18. Fletcher C., and Peto R. The natural history of chronic airflow obstruction. Br Med J 1 (1977) 1645-1648
19. Laurell C.-B., and Eriksson S. The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 15 (1963) 132-140
20. Laurell C.-B. Studies on the transportation and metabolism of iron in the body. Acta Physiol Scand 14 (1947) 1-129
21. Holmberg C.G., and Laurell C.-B. Investigations in serum copper. II. Isolation of the copper containing protein, and a description of some of its properties. Acta Chem Scand 2 (1948) 550-556
22. Laurell C.-B., and Nyman M. Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin. Blood 12 (1957) 493-506
23. Laurell C.-B., Laurell H., and Waldenström J. Glycoproteins in serum from patients with myeloma, macroglobulinemia and related conditions. Am J Med 22 (1957) 24-36
24. de Serres F.J. Worldwide racial and ethnic distribution of alpha-1-antitrypsin deficiency: details of an analysis of published genetic epidemiological surveys. Chest 122 (2002) 1818-1829
25. Crystal R.G., Brantly M.L., Hubbard R.C., et al. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest 95 1 (1989) 196-208
26. Janus E.D., Phillips N.T., and Carrell R.W. Smoking, lung function, and alpha-1 antitrypsin deficiency. Lancet 1 8421 (1985) 152-154
27. Hersh C.P., Demeo D.L., Lazarus R., et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 9 (2006) 977-984
28. DeMeo D.L., Hersh C.P., Hoffman E.A., et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 176 1 (2007) 42-48
29. Moshammer H., Hoek G., Luttman-Gibson H., et al. Parental smoking and lung function in children: an international study. Am J Respir Crit Care Med 173 11 (2006) 1255-1263
30. Shaheen S.O., Barker D.J., Shiell A.W., et al. The relationship between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir Crit Care Med 149 3 Pt 1 (1994) 616-619
31. Marossy A.E., Strachen D.P., Rudnicka A.R., et al. Childhood chest illness and the rate of decline of adult lung function between ages 35 and 45 years. Am J Respir Crit Care Med 175 4 (2007) 355-359
32. Howling S.J., Northway Jr. W.H., Hansell D.M., et al. Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. Am J Roentgenol 174 5 (2000) 1323-1326
33. Motley H.L., Lang L.P., and Gordon B. Pulmonary emphysema and ventilation measurements in 100 anthracite coal miners with respiratory complaints. Am Rev Tuberc 59 3 (1949) 270-288
34. Leigh J., Driscoll T.R., Cole B.D., et al. Quantitative relation between emphysema and lung mineral content in coalworkers. Occup Environ Med 51 (1994) 400-407
35. Ulvestad B., Bakke B., Eduard W., et al. Cumulative exposure to dust causes accelerated decline in lung function in tunnel workers. Occup Environ Med 58 (2001) 663-669
36. Becklake M.R., Irwig L., Kielkowski D., et al. The predictors of emphysema in South African goldminers. Am Rev Respir Dis 135 (1987) 1234-1241
37. Hnizdo E., Sluis-Cremer G.K., and Abramowits J.A. Emphysema type in relation to silica dust exposure in South African gold miners. Am Rev Respir Dis 143 (1991) 1241-1247
38. Ozbay B., Uzun K., Arslan H., et al. Functional and radiological impairment in women highly exposed to indoor biomass fuels. Respirology 6 3 (2001) 255-258
39. The World Health report: 2002: Reducing risks, promoting healthy life (2002), Geneva (Switzerland) WHO
40. Zhong N., Wang C., Yao W., et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 176 8 (2007) 753-760
41. Fletcher C., Peto R., Tinker C., et al. The natural history of chronic bronchitis and emphysema. Toronto (1976), Oxford University Press, New York
42. Donaldson G.C., Seemungal T.A.R., Bhomik A., et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57 (2002) 847-852
43. 1 decline in patients with chronic obstructive lung disease. Am J Respir Crit Care Med 167 (2003) 1090-1095
44. Thabut G., Dauriat G., Stern J.B., et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127 (2005) 1531-1536
45. Eddahibi S., Chaouat A., Morrell N., et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 108 (2003) 1839-1844
46. Swallow E.B., Reyes D., Hopkinson N.S., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62 2 (2007) 115-120
47. Hopkinson N.S., Nickol A.H., Payne J., et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 4 (2004) 395-399
48. Hopkinson N.S., Li K.W., Kehoe A., et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 87 2 (2008) 385-390
49. Kohn H.N. Zur Histologie des indurirenden fibrinösen Pneumonia. Münch Med Woch 40 (1893) 42-45
50. Terry P.B., Traystman R.J., Newball H.H., et al. Collateral ventilation in man. N Engl J Med 298 1 (1978) 10-15
51. Cormier Y., Atton L., and Sériès F. Influence of lung volume hysteresis on collateral resistance in intact dogs. Lung 171 1 (1993) 43-51
52. Fletcher C.M., Peto R., Tinker C.M., et al. The natural history of chronic bronchitis and emphysema. An eight year study of early chronic obstructive lung disease in working men in London (1976), Oxford University Press, Oxford (UK)
53. Monsó E., Izquierdo J., Alonson J., et al. Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function. Respir Med 92 2 (1998) 221-227
54. Spencer S., Calverley P.M., Sherwood Burge P., et al. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 1 (2001) 122-128
55. Naunheim K.S., Wood D.E., Mohsenifah S., et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 82 (2006) 431-443
56. Martinez F.J., Foster G., Curtis J.L., et al. Predictors of mortality in patients with severe emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173 12 (2006) 1326-1334
57. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 10 (2004) 1005-1012
58. Martinez F.J., Han M.K., Andrei A.C., et al. Longitudinal changes in the Bode index predicts mortality in severe emphysema. Am J Respir Crit Care Med 178 (2008) 491-499
59. Connors Jr. A.F., Dawson N.V., Thomas C., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154 4 pt 1 (1999) 959-967
60. Kaplan R.M., Ries A.L., Reilly J., et al. Measurement of health-related quality of life in the national emphysema treatment trial. Chest 126 (2004) 781-789
61. Ucgun I., Metinas M., Moral H., et al. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respir Med 100 1 (2006) 66-74
62. Chu C.M., Chan V.L., Lin A.W., et al. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59 12 (2004) 1020-1025
63. Man W.D., Polkey M.I., Donaldson N., et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 329 7476 (2004) 1209-1211